Board of Trustees Meeting Minutes March 2025
Ongoing 340B Partnership with Currier Drug Highlighted
Trusted by teams at
Description
The CEO reported that RCHC maintains an ongoing partnership with Currier Drug under the 340B drug pricing program, which yields an average of $600,000 in net annual revenue for the hospital. This collaboration reduces drug costs for patients and supports hospital finances.
Contract Details
Vendor
CURRIER DRUG
Agency
Goodland Regional Medical Center, KS
Contract Type
OTHER
Document Date
March 25, 2025
Renewal Info
Ongoing 340B relationship; no specific renewal dates or terms described.
More from Goodland Regional Medical Center
Board of Trustees Meeting Minutes March 2025
Board of Trustees Meeting Minutes March 2025
Board of Trustees Meeting Minutes March 2025
Board of Trustees Meeting Minutes March 2025
BOARD OF TRUSTEES Meeting Minutes February 2025
Want to learn more?
Get alerts on contract renewals, new awards, and vendor activity.
Bring us your territory.
We'll show you what is forming.
See live SLED buying signals, source docs, decision-makers, contract context, and the next step into your CRM or pipeline.